Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement
dc.contributor.author | Loke, Paxton | |
dc.contributor.author | Hsiao, Kuang-Chih | |
dc.contributor.author | Chebar Lozinsky, Adriana | |
dc.contributor.author | Ashley, Sarah E. | |
dc.contributor.author | Lloyd, Melanie | |
dc.contributor.author | Pitkin, Sigrid | |
dc.contributor.author | Axelrad, Christine Jean | |
dc.contributor.author | Jayawardana, Kaushala S. | |
dc.contributor.author | Tey, Dean | |
dc.contributor.author | Su, Ee Lyn | |
dc.contributor.author | Robinson, Marnie | |
dc.contributor.author | Leung, Agnes Sy | |
dc.contributor.author | Dunn Galvin, Audrey | |
dc.contributor.author | Tang, Mimi LK | |
dc.contributor.funder | Murdoch Children’s Research Institute, Australia | en |
dc.contributor.funder | Australian Food Allergy Foundation | en |
dc.contributor.funder | State Government of Victoria | en |
dc.contributor.funder | Australian Government | en |
dc.contributor.funder | Royal Australasian College of Physicians | en |
dc.date.accessioned | 2022-05-05T11:17:14Z | |
dc.date.available | 2022-05-05T11:17:14Z | |
dc.date.issued | 2022-04-29 | |
dc.date.updated | 2022-05-04T15:47:21Z | |
dc.description | Research Letter | en |
dc.description.abstract | There are few data on long-term effects and quality of life impact of peanut OIT. PPOIT was shown to induce 8-week sustained unresponsiveness that persists to 3-years post-treatment after ad libitum peanut ingestion. PPOIT provides lasting benefits for children with peanut allergy, with long-lasting improvement in health-related quality of life. | en |
dc.description.sponsorship | State Government of Victoria (Operational Infrastructure Support Program); Australian Government (Research Training Scholarship); Murdoch Children’s Research Institute (Postgraduate Research Scholarship); Royal Australasian College of Physicians (Fellows Research Scholarship) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Loke, P., Hsiao, K.-C., Chebar Lozinsky, A., Ashley, S. E., Lloyd, M., Pitkin, S., Axelrad, C. J., Jayawardana, K. S., Tey, D., Su, E. L., Robinson, M., Leung, A. S., Dunn Galvin, A. and Tang, M. L. K. (2022) 'Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement', Clinical and Experimental Allergy. doi: 10.1111/cea.14137 | en |
dc.identifier.doi | 10.1111/cea.14137 | en |
dc.identifier.eissn | 1365-2222 | |
dc.identifier.issn | 0954-7894 | |
dc.identifier.journaltitle | Clinical and Experimental Allergy | en |
dc.identifier.uri | https://hdl.handle.net/10468/13145 | |
dc.language.iso | en | en |
dc.publisher | John Wiley & Sons, Inc. | en |
dc.rights | © 2022, John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Loke, P., Hsiao, K.-C., Chebar Lozinsky, A., Ashley, S. E., Lloyd, M., Pitkin, S., Axelrad, C. J., Jayawardana, K. S., Tey, D., Su, E. L., Robinson, M., Leung, A. S., Dunn Galvin, A. and Tang, M. L. K. (2022) 'Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement', Clinical and Experimental Allergy, doi: 10.1111/cea.14137, which has been published in final form at: https://doi.org/10.1111/cea.14137. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | en |
dc.subject | Peanut allergy | en |
dc.subject | Health-related quality of life | en |
dc.subject | Oral immunotherapy | en |
dc.subject | Probiotic | en |
dc.subject | Sustained unresponsiveness | en |
dc.title | Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Clin_Experimental_Allergy_-_2022_-_Loke_-_Probiotic_peanut_oral_immunotherapy_is_associated_with_long‐term_persistence_of_(1).pdf
- Size:
- 6.27 MB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: